Santi Yarlagadda, MD
Santi Yarlagadda, MD, is a cardiologist who specializes in advanced heart failure at National Jewish Health. Dr. Yarlagadda is in the Division of Cardiology.
- Assistant Professor
- Division of Cardiology
- Department of Medicine
- Previously a 5280 Top Doctor 2nd Year
Patient Ratings
4.8 out of 5
Programs and ServicesEducation
Education
- 2006 - 2010
- Albany Medical College, Albany, NY, MD
- 2002 - 2006
- The University of Texas at Austin, Austin, TX, BS, Major in Biology, Concentration in Cell & Molecular Biology
Residency
- 2010 - 2013
- Rush University Medical Center, Chicago, IL, Internal Medicine
Fellowship
- 2017
- The University of California, San Francisco, San Francisco, CA, Advanced Heart Failure and Cardiac Transplant Fellowship
- 2014 - 2017
- The University of Texas Health Science Center at Houston, Memorial Hermann Hospital, M.D. Anderson Cancer Center, LBJ Hospital of Harris County, Houston, TX, Cardiovascular Disease
Board Certification
2019: Advanced Heart Failure and Transplant Cardiology
2017: American Board of Internal Medicine - Cardiovascular Disease
2017: Level II Training in Echocardiography
2017: Level II Training in Invasive Cardiology
2013: American Board of Internal Medicine
Professional Memberships
International Society for Heart and Lung Transplant (ISHLT)
American College of Cardiology (ACC)
American Heart Association (AHA)
Publications
Higgins JP, Yang B, Herrin NE, Yarlagadda S, et al. “Consumption of Energy Beverage is Associated with Attenuation of Arterial Endothelial Flow-Mediated Dilatation.” World Journal of Cardiology. 2017; 9(2):162-166.
Shih MJ, Kakodkar SA, Kaid Y, Hassel JL, Yarlagadda S, Fogg LF, Madias C, Krishnan K, Torhman RG. “Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing.” Pacing and Clinical Electrophysiology. 2016; 39: 483–489.
Shih M, Kakodkar S, Kaid Y, Hassel J, Yarlagadda S, Fogg L, Madias C, Krishnan K, Trohman R. “Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing.” American Heart Association Scientific Sessions, November 10, 2015, Orlando, FL
Higgins JP, Yarlagadda S, Yang B. “Cardiovascular Complications of Energy Drinks.” Beverages. 2015; 1(2): 104-126.
Gallichio M, Yarlagadda S., Rainow A, Conti D. “Dialysis Time is a Risk Factor for Long-Term Deceased-Donor Transplant Survival.” Transplantation, supplement 2S, 86:41, 2008
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.
The Patient metric-rating score is an average of all responses to
care provider related questions on our independent metric-rating
system, the Press Ganey Patient Satisfaction Survey. This survey is
about the patient care experience and does not address crucial
characteristics like medical decision-making, prescribing the best
therapy, and patient outcomes.
